NRG Therapeutics

energizing drug discovery in neurodegenerative diseases

Stevenage, United Kingdom · $87.3M raised

Headquarters
Stevenage
Employees
11–50
Business Model
B2B
Total Funding
$87.3M
Last Round
$67.0M Series BSep 2025
Rounds
2

About

NRG Therapeutics is leveraging breakthrough science in mitochondrial biology and disease mechanisms to develop novel medicines to treat neurodegenerative disorders. The company's pipeline of first-in-class, CNS-penetrant, oral small molecules is based on inhibiting the mitochondrial permeability transition pore (mPTP) through a novel mechanism of action. Its lead drug candidate NRG5051 commenced a first-in-human clinical trial in 2026.

Summary

NRG Therapeutics is a Biotech company based in Stevenage, United Kingdom. It has raised $87.3M in total across 2 rounds, most recently a $67.0M Series B round in Sep 2025. Investors include M Ventures, SV Health Investors and Omega Funds.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2025
$67.0M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NRG Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/nrg-therapeutics"><img src="https://indexed.vc/api/badge/company/nrg-therapeutics" alt="NRG Therapeutics on Indexed.vc" width="260" height="76" /></a>